Saūda Arābija - angļu - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pfizer - piroxicam - suppository - 20 mg

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - piroxicam 20 mg - suppository - 20 mg - piroxicam 20 mg - piroxicam

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - piroxicam 20mg;   - suppository - 20 mg - active: piroxicam 20mg  

Kanāda - angļu - Health Canada

pharmascience inc - piroxicam - suppository - 20mg - piroxicam 20mg - other nonsteroidal antiimflammatory agents

Kanāda - angļu - Health Canada

pfizer canada ulc - piroxicam - suppository - 20mg - piroxicam 20mg - other nonsteroidal antiimflammatory agents

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - piroxicam - suppository - 20mg

Ēģipte - angļu - EDA (Egyptian Drug Authority)

pfizer-egypt - suppository - 20 mg

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - piroxicam, quantity: 20 mg - tablet, dispersible - excipient ingredients: sodium stearylfumarate; microcrystalline cellulose; hyprolose; lactose monohydrate - feldene is indicated for symptomatic treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - piroxicam, quantity: 10 mg - capsule, hard - excipient ingredients: lactose monohydrate; sodium lauryl sulfate; maize starch; magnesium stearate - feldene is indicated for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis.

Namībija - angļu - Namibia Medicines Regulatory Council

pfizer laboratories (pty) ltd - piroxicam - suppository - each suppository contains 20mg piroxicam